← Evidence map

ArticleProceedings of the National Academy of Sciences of the United States of America2013

XPLN is an endogenous inhibitor of mTORC2.

Nidhi Khanna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

34 papers cite it

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 24043828